Electronics producers Samsung and Omron Healthcare, have supplied an undisclosed amount of funding for US-based respiratory disease management platform developer Cohero Health, the former through its Samsung Next unit, adding to a series A round that stood at $9m as of November 2016. A securities filing indicates Cohero had raised an additional $4.3m as of last month, and investors in the first tranche include manufacturing group Heitkamp & Thumann, and corporate venturing units Zaffre Investments and GIS Strategic Ventures.
…
